Sodium Sulfate

硫酸钠

Report date: 2026/05/22 20:01:29

Base Information

Drug NameSodium Sulfate
Drug Alias Name硫酸钠sodium sulfide无水硫酸钠hydrogen sulfide硫酸鈉 +[7] 
ClassificationSmall molecules > Inorganic and minerals salt
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIschemiaMyocardial InfarctionMyocardial Ischemia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFred Hutchinson Cancer Research Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMallinckrodtFred Hutchinson Cancer Research Center
Active IndicationsN/A
Inactive IndicationsIschemiaMyocardial InfarctionMyocardial Ischemia +[4] 

Other Information

ATC CodeA06AD13A12CA02
Related LinksN/A